Neoadjuvant Chemoimmunotherapy

Neoadjuvant Chemoimmunotherapy is a therapeutic strategy that integrates chemotherapy and immunotherapy as a combined modality administered prior to definitive surgery or primary treatment to enhance antitumor immune responses and reduce tumor burden in the neoadjuvant setting.

235

Publications

13.9K

Citations

2.6K

Authors

733

Institutions

Publications per year

2017–2026

170

Authors

2.6K

  1. MP
    Mariano Provencio

    Hospital Universitario Puerta de Hierro Majadahonda, Spain

    10 publications · 381 citations

    10

    h-index

  2. BM
    Bartomeu Massutí

    Hospital General Universitario de Alicante Doctor Balmis, Spain

    8 publications · 357 citations

    8

    h-index

  3. AI
    Amelia Insa

    Hospital Clínico Universitario de Valencia, Spain

    8 publications · 357 citations

    8

    h-index

  4. DR
    Delvys Rodríguez‐Abreu

    Hospital Universitario Insular de Gran Canaria, Spain

    7 publications · 294 citations

    7

    h-index

  5. EN
    Ernest Nadal

    Institut Català d'Oncologia, Spain

    7 publications · 289 citations

    7

    h-index

1–5 of 2.6K

Venues

  1. Journal of Clinical Oncology

    14 publications · 449 citations

    12

    h-index

  2. Frontiers in Immunology

    11 publications · 426 citations

    11

    h-index

  3. Frontiers in Oncology

    9 publications · 169 citations

    8

    h-index

  4. PubMed

    Repository · 7 publications · 262 citations

    7

    h-index

  5. Annals of Oncology

    7 publications · 246 citations

    7

    h-index

1–5